ICAM2 is a transmembrane glycoprotein, and erythroblast transformation-specific-related gene (ERG)-induced ICAM2 can inhibit tumor proliferation and metastasis by enhancing ubiquitination and degradation of radixin (RDX) 46. This evidence concerns the gene ERG and neoplasm.